Transposable elements (TEs) are transcriptionally activated in cancer and can generate chimeric TE–gene transcripts that are tumor specific. Our pan-cancer study reveals that these transcripts are a source of tumor-specific antigens that are shared across tumor types, bind to HLA and are presented on the extracellular surface of cancer cells appended to membrane-bound proteins.
References
June, C. H. et al. CAR T cell immunotherapy for human cancer. Science 359, 1361–1365 (2018). This review article is on chimeric antigen receptor T cell therapy in cancer.
Laumont, C. M. et al. Noncoding regions are the main source of targetable tumor-specific antigens. Sci. Transl. Med. 10, 470 (2018). This paper identifies non-coding regions as an important source of tumor-specific antigens.
Burns, K. H. Transposable elements in cancer. Nat. Rev. Cancer. 17, 415–424 (2017). This review article explores the role of TEs in cancer.
Babaian, A. & Mager, D. L. Endogenous retroviral promoter exaptation in human cancer. Mob. DNA 7, 24 (2016). This review article presents the phenomenon of onco-exaptation, in which TEs act as alternative promoters for oncogenes.
Jang, H. S. et al. Transposable elements drive widespread expression of oncogenes in human cancers. Nat. Genet. 51, 611–617 (2019). This paper comprehensively profiles onco-exaptation in 15 cancer types.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Shah, N. M. et al. Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements. Nat. Genet. https://doi.org/10.1038/s41588-023-01349-3 (2023).
Rights and permissions
About this article
Cite this article
Chimeric transcripts of transposable elements and genes are a source of tumor-specific antigens. Nat Genet 55, 538–539 (2023). https://doi.org/10.1038/s41588-023-01361-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-023-01361-7
- Springer Nature America, Inc.